Avidity Biosciences Inc share price logo

Avidity Biosciences Inc Share Price

NASDAQ: RNA

Mid Cap

$44.70

+3.66

(+8.93%)

as on

Avidity Biosciences Inc Stock Performance

as on September 13, 2025 at 1:29 am IST

  • Day's Low

    Day's High

    $42.97
    $46.23
    downward going graph

    3.87%

    Downside

    3.42%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $21.51
    $56
    downward going graph

    51.88%

    Downside

    25.28%

    Upside

    downward going graph

Avidity Biosciences Inc share price movements today

Previous Close
$41.04
Open
$43.02
Volume
9.4M
Day's Low - High
$42.97 - $46.23
52 Week Low - High
$21.51 - $56

Avidity Biosciences Inc Historical Returns

1 Month Return
-11.07 %
3 Month Return
+ 30.83 %
1 Year Return
-1.61 %
3 Year Return
+ 107.17 %
5 Year Return
0 %

Avidity Biosciences Inc Stock Fundamentals & Key Indicators

Check Avidity Biosciences Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$5.3B

EPS (TTM)

-4.506

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-18.55

Industry PE ratio

10.127857142857144

P/B Ratio

0

PEG Ratio

0

EBITDA

-518.7M

Revenue (TTM)

10.7M

Profit Margin

0.00%

Return On Equity TTM

0.00%

Avidity Biosciences Inc Stock Valuation

Track how Avidity Biosciences Inc P/E has moved over time to understand its valuation trends.

Avidity Biosciences Inc in the last 5 years

  • Overview

  • Trends

Lowest (0.00x)

September 13, 2025

Today (-18.55x)

September 13, 2025

Industry (10.13x)

September 13, 2025

Highest (0.00x)

September 13, 2025

LowHigh

Today’s Price to Earnings Ratio: -18.55x

Avidity Biosciences Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Avidity Biosciences Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$5.3BNA-18.550.00%
BUY$61.1B280.5%-505.15-12.96%
NA$37.7BNANA-3.89%
BUY$101.2B54.04%28.0831.86%
BUY$59.4B2.03%14.1131.37%

Stock Returns calculator for Avidity Biosciences Inc Stock including INR - Dollar returns

The Avidity Biosciences Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Avidity Biosciences Inc investment value today

Current value as on today

₹1,12,308

Returns

₹12,308

(+12.31%)

Returns from Avidity Biosciences Inc Stock

₹7,169 (+7.17%)

Dollar Returns*

₹5,139 (+5.14%)

Analyst Recommendation on Avidity Biosciences Inc Stock

Based on 12 analysts

BUY

91.67%

Buy

8.33%

Hold

0.00%

Sell

Based on 12 analysts, 91.67% of analysts recommend a 'BUY' rating for Avidity Biosciences Inc. Average target price of $67.39

Avidity Biosciences Inc Share Price Target

Get share price movements and forecasts by analysts on Avidity Biosciences Inc.

What analysts predicted

33.67%UPSIDE

Target Price

$67.39

Current Price

$44.7

Analyzed by

12 Analysts

Target

$67.39

Avidity Biosciences Inc target price $67.39, a slight upside of 33.67% compared to current price of $44.7. According to 12 analysts rating.

Avidity Biosciences Inc Stock's Interest Amongst Investors

Investment in Avidity Biosciences Inc Shares on INDmoney has grown by 268.57% over the past 30 days, indicating increased transactional activity.

Time period: to

Change:268.57% versus previous 30 day period

Search interest for Avidity Biosciences Inc Stock has decreased by -45% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-45% versus previous 30 day period

Avidity Biosciences Inc Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
2
2
2
2
3
2
2
2
1
3
Gross Profit
1
1
3
1
2
1
2
2
1
3
Operating Income
-52
-52
-58
-66
-77
-82
-98
-120
-131
-171
EBITDA
-57
-52
-58
-66
-76
-81
-97
-120
-130
-171
Interest Expense
0
-
-
0
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-52
-47
-52
-60
-68
-70
-80
-102
-115
-157
Income Tax Expense
-5
-5
-6
0
0
-
-
-
-
-
Net Income
-47
-47
-52
-60
-68
-70
-80
-102
-115
-157
Net Profit Margin
-2113.39%
-2030.44%
-1857.98%
-2756.18%
-1943.41%
-3461.76%
-3441.70%
-3439.52%
-7360.01%
-4089.29%

Avidity Biosciences Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
0
2
6
9
9
9
10
Gross Profit
-8
-12
6
9
9
7
10
Operating Income
-10
-17
-44
-118
-178
-235
-378
EBITDA
-10
-16
-43
-117
-177
-233
-376
Interest Expense
0
7
0
0
5
-
-
Depreciation
0
0
0
0
1
1
2
Income Before Tax
-11
-24
-44
-118
-173
-212
-322
Income Tax Expense
0
7
0
0
-4
1
-
Net Income
-11
-24
-43
-117
-169
-212
-322
Net Profit Margin
-3148.81%
-1066.58%
-648.03%
-1258.52%
-1833.01%
-2219.87%
-2957.71%

Avidity Biosciences Inc Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
-47
-52
-60
-68
-70
-80
-102
-115
-157
Operating Cash Flow
-49
-36
16
-70
-65
-65
-99
-124
-199
Investing Cash Flow
46
-31
51
-32
-274
-482
-64
157
185
Financing Cash Flow
38
0
31
389
446
342
13
1
3
Change in Cash
35
-68
99
286
106
-205
-150
34
-10

Avidity Biosciences Inc Annual Cash Flow

All numbers in Millions USD

Dec 2012
Dec 2013
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-
-
-11
-24
-44
-118
-173
-212
-322
Operating Cash Flow
-
-
-9
2
-37
-94
-136
-119
-300
Investing Cash Flow
-
-
0
0
-7
-82
-189
-130
-854
Financing Cash Flow
34
88
5
89
272
176
346
93
1,192
Change in Cash
-
-
-4
91
227
-1
19
-155
37

Global Institutional Holdings in Avidity Biosciences Inc

Funds
Holdings
Alethea Capital Management, LLC
0.33%

Insights on Avidity Biosciences Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 1.57M → 3.84M (in $), with an average increase of 59.1% per quarter

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, RNA has outperformed top 5 stocks with highest market-cap in its industry

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 75.7% return, outperforming this stock by 68.5%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 9 quarters, -47.02M → -157.31M (in $), with an average decrease of 16.7% per quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, RNA stock has moved down by -11.2%

About Avidity Biosciences Inc

avidity biosciences is pioneering a new class of precision medicines – antibody-sirna conjugates (asc™) – to deliver nucleic acid therapeutics against genetic drivers of disease. our ascs have drug-like properties similar to antibodies and antibody-drug conjugates. importantly, their unique sirna-based “payloads” permit selective targeting of disease-associated mrnas against virtually any target of interest. our leadership includes seasoned scientists and executives with deep expertise in the fields of antibody conjugation, chemistry, formulations, oligonucleotide therapeutics, drug delivery and cancer biology. our employees are high energy, creative people who are passionate about solving hard problems and bringing new drugs to patients. we strive to work with partners to discover best-in-class molecules with the goal of long-term, joint value creation. we have also attracted support from top-tier investors including f-prime capital, ecor1 capital, brace pharma and other sophisticated
OrganisationAvidity Biosciences Inc
Headquarters10578 Science Center Drive, San Diego, CA, United States, 92121
IndustryHealth Technology
CEOMs. Sarah Boyce
E-voting on sharesClick here to vote

Key Management of Avidity Biosciences Inc

Name

Title

Mr. Eric B. Mosbrooker

Chief Commercial Officer

Dr. Steven George Hughes M.B.A., M.D.

Chief Medical Officer

Dr. W. Michael F. Flanagan Ph.D.

Chief Scientific Officer

Mr. John B. Moriarty Jr., ESQ., J.D.

Chief Legal Officer & Corporate Secretary

Ms. Teresa McCarthy

Chief Human Resources Officer

Prof. Mark E. Davis Ph.D.

Scientific Founder, Member of Scientific Advisory Board and Member of Board of Managers

Dr. Frank P. McCormick Ph.D.

Scientific Founder & Member of Scientific Advisory Board

Mr. Charles Calderaro III

Chief Technical Officer

Dr. Troy Edward Wilson J.D., Ph.D.

Co-Founder & Independent Chairman

Ms. Sarah Boyce

President, CEO & Director

FAQs

What is Avidity Biosciences Inc share price today?

Avidity Biosciences Inc share price today is $44.7 as on at the close of the market. Avidity Biosciences Inc share today touched a day high of $46.23 and a low of $42.97.

What is the 52 week high and 52 week low for Avidity Biosciences Inc share?

Avidity Biosciences Inc share touched a 52 week high of $56 on and a 52 week low of $21.51 on . Avidity Biosciences Inc stock price today i.e. is closed at $44.7,which is 20.18% down from its 52 week high and 107.81% up from its 52 week low.

What is Avidity Biosciences Inc's market capitalisation today?

Avidity Biosciences Inc market capitalisation is $0.01T as on .

How to invest in Avidity Biosciences Inc Stock (RNA) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Avidity Biosciences Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Avidity Biosciences Inc Shares that will get you 0.0336 shares as per Avidity Biosciences Inc share price of $44.7 per share as on September 13, 2025 at 1:29 am IST.

What is the minimum amount required to buy Avidity Biosciences Inc Stock (RNA) from India?

Indian investors can start investing in Avidity Biosciences Inc (RNA) shares with as little as ₹88.27 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹882.70 in Avidity Biosciences Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Avidity Biosciences Inc share’s latest price of $44.7 as on September 13, 2025 at 1:29 am IST, you will get 0.2237 shares of Avidity Biosciences Inc. Learn more about fractional shares .